LVNSF - Leonovus Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
5
5
78
327
31.3505
Operating Expenses
Research Development
730
575
748
748
2,563
Selling General and Administrative
1,334
1,054
1,569
1,270
3,357
Total Operating Expenses
2,247
1,811
2,502
2,018
5,920
Operating Income or Loss
-2,242
-1,806
-2,424
-1,691
-5,889
Interest Expense
100
117
116
199
108.4204
Total Other Income/Expenses Net
156
-1,165
58
108
-786.3745
Income Before Tax
-2,188
-3,088
-2,581
-1,802
-6,783
Income from Continuing Operations
-2,188
-3,088
-2,581
-1,802
-6,783
Net Income
-2,188
-3,088
-2,581
-1,802
-6,783
Net Income available to common shareholders
-2,188
-3,088
-2,581
-1,802
-6,783
Basic EPS
-
-
-0.13
-0.19
-0.74
Diluted EPS
-
-
-0.13
-0.19
-0.74
Basic Average Shares
-
-
18,780
9,561
9,288
Diluted Average Shares
-
-
18,780
9,561
9,288
EBITDA
-
-2,789
-2,278
-1,421
-6,497